This is a study looking at a new way to evaluate vascular problems or tumors in brain surgery patients using a standard \& approved intravenous dye and augmented reality.
This is a study investigating a new technique with an approved medication (ICG or indocyanine green) and using that and a near infrared mode on a standard operating room microscope to see the information provided for vascular or neoplastic (tumor related) neurosurgical problems. The technique uses the data from the microscope and using ICG with augmented reality overlaying the data into the microscope view (this is the new process). The technique is called GLOW800.
Study Type
OBSERVATIONAL
Enrollment
7
The treatment group will consist of patients who require a medically necessary craniotomy. If an investigator deems that it will be useful to see blood vessels better with indocyanine green (ICG) videoangiography (VA), patients may be consented for the use if ICG VA using augmented reality (GLOW800). This will not add additional time or risk to their surgery
This is a standard medication which can be given IV during a surgery to better visualize blood vessels under the microscope
Cedars-Sinai Medical Center
Los Angeles, California, United States
Usefulness of Glow800 Technique
Surgeon assessment of Glow800 compared to ICG-VA in usefulness
Time frame: 48 hours
Utility in Identifying a lesion
Surgeon assessment of Glow800 vs ICG-VA in identifying vascular structures (useful, somewhat useful, not useful)
Time frame: 48 hours
Surgical workflow
Surgeon assessment of whether there is additional time (no additional time, \<15 minutes additional time, \<30 minutes additional time, \>30 minutes additional time)
Time frame: 48 hours
Additional Cost
Surgeon assessment as to whether there is additional cost at surgery
Time frame: 48 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.